FLT4 and breast cancer: In our study, FLT4 mutations were prevalent among breast angiosarcomas (n = 11, 15.1%) and did co-occur with MYC amplifications (p < 0.001), consistent with the theory that many breast angiosarcomas develop secondary to radiation for primary breast cancer.